Earnings Feed
Start Free
Theravance Biopharma, Inc.·4

Feb 23, 6:07 PM ET

Hindman Andrew A. 4

4 · Theravance Biopharma, Inc. · Filed Feb 23, 2021

Insider Transaction Report

Form 4
Period: 2021-02-20
Theravance Biopharma, Inc.TBPH
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2021-02-20$18.79/sh−3,984$74,859→ 184,704 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -